IRUBIS
Responsible for developing innovative processes for manufacturing using spectroscopy.
- biotechnology
- horizon europe
- dt and ls
- woman founder
- spinout
- space tech
- esa
- eit ecosystem
- space upstream
- eit health
- esa bic
- nif defense security and resilience
- eit supernovas
- optical technology
- eicfund
- nif health crisis preparedness
- in-space operations
- health information
- investor network (eit health)
- nif biotech
- investor network 2019 (eit health)
- in-space research
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
* | N/A | Early VC | |
| Total Funding | 000k | ||
| EUR | 2021 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Developer of a bioprocess monitoring instrument designed to make online monitoring and control of bioreactors by mid-infrared spectroscopy become standard. The company's instrument is used for upstream bioprocessing in metabolite monitoring and in downstream bioprocessing for aggregation studies, contaminant detection and monitoring of target proteins and excipients with the help of MIR spectroscopy sensor and machine-learning evaluation software, enabling laboratory researchers to realize continuous monitoring and control of the nutrient concentration of blood samples and related aqueous fluids.
Keywords: Healthcare Devices / Services / Supplies, Pharmaceuticals and Biotechnology, Biofluid Analysis, Biofluid Analyzers, Bioprocess Monitoring, Blood Sampling, Blood Testing Device, Infrared Spectroscopy, Infrared Spectroscopy Analyzers, Mir Spectroscopy.